Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eszopiclone for the Treatment of PTSD

NCT01605253 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.

NCT NCT01605253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01605253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eszopiclone for the Treatment of PTSD
Lead sponsor
Rush University Medical Center
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2012
Completion date
December 31, 2015
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

posttraumatic stress disorders